Total
0
Shares
Field Trip Health - President, Hannan Fleiman.
President, Hannan Fleiman.
Source: Field Trip Health.
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Field Trip Health (FTRP) is announcing new psychedelic-assisted therapy centers in Seattle, Vancouver and Fredericton
  • The Fredericton and Seattle clinics are now open with Vancouver soon to follow
  • The expansion is in line with positive client results and growing demand for the company’s ketamine-assisted treatments
  • Field Trip Health is a global leader in the development and delivery of psychedelic therapies
  • Field Trip Health (FTRP) is down by 5.83 per cent and is currently trading at $7.11 per share

Field Trip Health (FTRP) is announcing new psychedelic-assisted therapy centers in Seattle, Vancouver and Fredericton.

The Seattle clinic, opening today, represents its sixth in the United States.

The Fredericton, New Brunswick facility, also recently opened, comes ahead of the imminent opening of the Vancouver location.

As the largest global provider of psychedelic-assisted therapies, Field Trip remains focused on expansion in line with growing demand.

Since opening its first location in March 2020, the company’s ketamine-assisted therapy (KAP) protocols have improved clients’ depression symptoms from severe to mild on average – with the mean respondent PHQ9 score decreasing from 17 to 6.

Respondents reported that benefits were sustained for 120 days or longer from commencement of treatment. These results suggest that Field Trip’s KAP program may compare favourably to ketamine infusions.

Field Trip Health centers are designed to provide an oasis-like and nature-based setting that serves as a space for healing, growth and transformation through psychedelic therapies.

Dr. Ryan Yermus, Field Trip Health’s Chief Clinical Officer, stated,

“Since our first clinic opening in Toronto, we have demonstrated the transformative power of our psychedelic-assisted therapy protocols for people struggling with their mental health. As we continue to grow into new markets, the potential to positively change people’s lives is endless. We are incredibly excited to deliver best-in-class psychedelic therapies to the communities in Seattle, Vancouver and Fredericton.”

Hannan Fleiman, Field Trip’s President, added,

“Every center opening lays the groundwork for the development of new psychedelic therapies. Not only are we healing the community with the delivery of psychedelic medicine to patients, but we are also ensuring the evolution of the psychedelic reawakening that is happening in the field of mental health.”

Field Trip Health is a global leader in the development and delivery of psychedelic therapies.

Field Trip Health (FTRP) is down by 5.83 per cent and is currently trading at $7.11 per share as of 11:23 am ET.

More From The Market Herald
BioMark Diagnostics - Founder and CEO, Rashid Bux

" BioMark (CSE:BUX) to collaborate with AstraZeneca and Pfizer Canada to improve early detection of lung cancer

BioMark Diagnostics (BUX) will participate in a research project that aims to enhance the efficiency of lung cancer screening programs.

" Algernon Pharmaceuticals (CSE:AGN) welcomes new CFO

Algernon Pharmaceuticals (AGN) has appointed Mr. James Kinley as the Chief Financial Officer (CFO), effective December 1, 2021.

" Beyond Medical Technologies (CSE:DOCT) ramps up mask manufacturing in response to new South African variant

Beyond Medical Technologies (DOCT) subsidiary Micron Technologies has been manufacturing medical masks in British Columbia since August 2020.

" Sun Life Financial (TSX:SLF) partners with CloudMD (TSXV:DOC)

Sun Life (SLF) has partnered with CloudMD (DOC) to add its Mental Health Coach solution to group benefits plans.